LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 5616

Search options

  1. Article ; Online: Glutathione depletion results in S-nitrosylation of protein disulfide isomerase in neuroblastoma cells.

    Ono, Shinji / Ogura, Jiro / Sugiura, Hiroki / Yamauchi, Minami / Tanaka, Atsushi / Sato, Toshihiro / Maekawa, Masamitsu / Yamaguchi, Hiroaki / Mano, Nariyasu

    Life sciences

    2023  Volume 316, Page(s) 121442

    Abstract: ... protein folding. PDI is S-nitrosylated in the brains of Alzheimer's disease patients, and S-nitrosylated PDI is ... considered one of main causes of Alzheimer's disease. However, the mechanisms underlying PDI S-nitrosylation ... of Alzheimer's disease, we investigated the effect of GSH depletion on the S-nitrosylation level of PDI.: Main methods ...

    Abstract Aims: Protein disulfide isomerase (PDI) is an essential enzyme involved in oxidative protein folding. PDI is S-nitrosylated in the brains of Alzheimer's disease patients, and S-nitrosylated PDI is considered one of main causes of Alzheimer's disease. However, the mechanisms underlying PDI S-nitrosylation have not yet been elucidated. Because glutathione (GSH) depletion is a pathological feature of Alzheimer's disease, we investigated the effect of GSH depletion on the S-nitrosylation level of PDI.
    Main methods: SH-SY5Y cells, which is a human derived neuroblastoma cells, were used in this study. Glutamate and buthionine sulfoximine (BSO) were used as GSH depletors. S-nitrosylated PDI was detected by biotin-switch assay.
    Key findings: GSH depletion by glutamate, a cystine/glutamate antiporter xCT inhibitor, increased S-nitrosylated PDI at C343 in SH-SY5Y cells, and induced IRE1α phosphorylation. BSO, a γ-glutamylcysteine synthetase inhibitor, also increased S-nitrosylated PDI and phosphorylated IRE1α upon GSH depletion. Because S-nitrosylated PDI at C343 is stable in neuro cells, S-nitrosylated PDI by GSH depletion progresses to neurodegeneration by the induction of endoplasmic reticulum stress via phosphorylated IRE1α signaling from the early to late stage. Furthermore, treatment with neohesperidin, but not N-acetylcysteine (NAC), improved PDI S-nitrosylation level in GSH-depleted SH-SY5Y cells because nitrosylated compound of NAC induces PDI S-nitrosylation.
    Significance: The results of our study provide a new insight into the mechanisms of neurodegeneration, and may be useful for the development of drugs for Alzheimer's diseases.
    MeSH term(s) Humans ; Protein Disulfide-Isomerases/metabolism ; Alzheimer Disease ; Endoribonucleases ; Neuroblastoma/pathology ; Protein Serine-Threonine Kinases ; Glutathione ; Glutamates
    Chemical Substances Protein Disulfide-Isomerases (EC 5.3.4.1) ; Endoribonucleases (EC 3.1.-) ; Protein Serine-Threonine Kinases (EC 2.7.11.1) ; Glutathione (GAN16C9B8O) ; Glutamates
    Language English
    Publishing date 2023-01-26
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2023.121442
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Randomized phase II trial of chemoradiotherapy with S-1 versus combination chemotherapy with gemcitabine and S-1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC 04).

    Sugiura, Teiichi / Toyama, Hirochika / Fukutomi, Akira / Asakura, Hirofumi / Takeda, Yuriko / Yamamoto, Kouji / Hirano, Satoshi / Satoi, Sohei / Matsumoto, Ippei / Takahashi, Shinichiro / Morinaga, Soichiro / Yoshida, Makoto / Sakuma, Yasunaru / Iwamoto, Hidetaka / Shimizu, Yasuhiro / Uesaka, Katsuhiko

    Journal of hepato-biliary-pancreatic sciences

    2023  Volume 30, Issue 11, Page(s) 1249–1260

    Abstract: ... chemoradiotherapy (NAC-RT) with S-1 or combination neoadjuvant chemotherapy with gemcitabine and S-1 (NAC-GS), is ... of effectiveness and safety.: Methods: In the NAC-RT with S-1 group, the patients received a total radiation ... dose of 50.4 Gy in 28 fractions with oral S-1. In the NAC-GS group, the patients received intravenous ...

    Abstract Objective: The aim of the present study was to investigate which treatment, neoadjuvant chemoradiotherapy (NAC-RT) with S-1 or combination neoadjuvant chemotherapy with gemcitabine and S-1 (NAC-GS), is more promising as neoadjuvant treatment (NAT) for resectable pancreatic cancer in terms of effectiveness and safety.
    Methods: In the NAC-RT with S-1 group, the patients received a total radiation dose of 50.4 Gy in 28 fractions with oral S-1. In the NAC-GS group, the patients received intravenous gemcitabine at a dose of 1000 mg/m
    Results: From April 2014 to April 2017, a total of 103 patients were enrolled. After exclusion of one patient because of ineligibility, 51 patients were included in the NAC-RT with S-1 group, and 51 patients were included in the NAC-GS group in the intention-to-treat analysis. The 2-year PFS rate was 45.0% (90% confidence interval [CI]: 33.3%-56.0%) in the NAC-RT with S-1 group and 54.9% (42.8%-65.5%) in the NAC-GS group (p = .350). The 2-year overall survival rate was 66.7% in the NAC-RT with S-1 group and 72.4% in the NAC-GS group (p = .300). Although leukopenia and neutropenia rates were significantly higher in the NAC-GS group than in the NAC-RT with S-1 group (p = .023 and p < .001), other adverse events of NAT and postoperative complications were comparable between the two groups.
    Conclusion: Both NAC-RT with S-1 and NAC-GS are considered promising treatments for resectable pancreatic cancer.
    MeSH term(s) Humans ; Chemoradiotherapy ; Gemcitabine ; Neoadjuvant Therapy/adverse effects ; Pancreatic Neoplasms
    Chemical Substances Gemcitabine
    Language English
    Publishing date 2023-09-25
    Publishing country Japan
    Document type Clinical Trial, Phase II ; Randomized Controlled Trial ; Journal Article
    ZDB-ID 2536236-7
    ISSN 1868-6982 ; 1868-6974
    ISSN (online) 1868-6982
    ISSN 1868-6974
    DOI 10.1002/jhbp.1353
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Probing the proton release by Photosystem II in the S

    Boussac, Alain / Sugiura, Miwa / Sellés, Julien

    Biochimica et biophysica acta. Bioenergetics

    2022  Volume 1863, Issue 5, Page(s) 148546

    Abstract: ... of the S-state cycle in Photosystem II (PSII) from Thermosynechococcus elongatus containing either a Mn ...

    Abstract The stoichiometry and kinetics of the proton release were investigated during each transition of the S-state cycle in Photosystem II (PSII) from Thermosynechococcus elongatus containing either a Mn
    MeSH term(s) Cyanobacteria/metabolism ; Electron Transport ; Oxidation-Reduction ; Photosystem II Protein Complex/metabolism ; Protons
    Chemical Substances Photosystem II Protein Complex ; Protons
    Language English
    Publishing date 2022-03-23
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 60-7
    ISSN 1879-2650 ; 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2642 ; 1879-2618 ; 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    ISSN (online) 1879-2650 ; 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2642 ; 1879-2618
    ISSN 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    DOI 10.1016/j.bbabio.2022.148546
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202.

    Kobayashi, Shogo / Nakachi, Kohei / Ikeda, Masafumi / Konishi, Masaru / Ogawa, Gakuto / Sugiura, Teiichi / Yanagimoto, Hiroaki / Morinaga, Soichiro / Wada, Hiroshi / Shimada, Kazuaki / Takahashi, Yu / Nakagohri, Toshio / Kamata, Ken / Shimizu, Yasuhiro / Ajiki, Tetsuo / Hirano, Satoshi / Gotohda, Naoto / Ueno, Makoto / Okusaka, Takuji /
    Furuse, Junji

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

    2023  Volume 50, Issue 2, Page(s) 107324

    Abstract: ... the superiority of adjuvant S-1 chemotherapy for biliary tract cancer (BTC). The aim of this study is to examine ... the influence of MH for BTC on adjuvant S-1.: Materials and methods: Of the total 424 patients, 207 received ... S-1 (S-1 arm) while the remaining 217 were not. We compared MH with non-major hepatectomy (NMH ...

    Abstract Introduction: Major hepatectomy (MH) may produce the impaired liver function and affect the feasibility of adjuvant chemotherapy in terms of early period after the surgery, but there have not been detailed investigations. JCOG1202 (UMIN000011688) is a randomized phase III trial demonstrating the superiority of adjuvant S-1 chemotherapy for biliary tract cancer (BTC). The aim of this study is to examine the influence of MH for BTC on adjuvant S-1.
    Materials and methods: Of the total 424 patients, 207 received S-1 (S-1 arm) while the remaining 217 were not. We compared MH with non-major hepatectomy (NMH) for BTC.
    Results: In the S-1 arm, 42 had undergone MH, and 165 had undergone NMH. MH had similar pretreatment features to NMH, including the proportion of biliary reconstruction, to NMH, except for a lower platelet count (17.7 vs. 23.4 × 10
    Conclusion: The treatment completion proportion and dose intensity were lower in MH than in NMH. Caution should be exercised against biliary tract infections and gastrointestinal disorders during adjuvant S-1 after MH for BTC.
    MeSH term(s) Humans ; Antineoplastic Combined Chemotherapy Protocols ; Biliary Tract Neoplasms/drug therapy ; Biliary Tract Neoplasms/surgery ; Chemotherapy, Adjuvant ; Feasibility Studies ; Gastrointestinal Diseases/drug therapy ; Gastrointestinal Diseases/surgery ; Hepatectomy ; Randomized Controlled Trials as Topic ; Clinical Trials, Phase III as Topic
    Language English
    Publishing date 2023-12-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 632519-1
    ISSN 1532-2157 ; 0748-7983
    ISSN (online) 1532-2157
    ISSN 0748-7983
    DOI 10.1016/j.ejso.2023.107324
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Glutathione depletion results in S-nitrosylation of protein disulfide isomerase in neuroblastoma cells

    Ono, Shinji / Ogura, Jiro / Sugiura, Hiroki / Yamauchi, Minami / Tanaka, Atsushi / Sato, Toshihiro / Maekawa, Masamitsu / Yamaguchi, Hiroaki / Mano, Nariyasu

    Life Sciences. 2023 Mar., v. 316 p.121442-

    2023  

    Abstract: ... is S-nitrosylated in the brains of Alzheimer's disease patients, and S-nitrosylated PDI is considered ... one of main causes of Alzheimer's disease. However, the mechanisms underlying PDI S-nitrosylation have ... of Alzheimer's disease, we investigated the effect of GSH depletion on the S-nitrosylation level of PDI. SH-SY5Y cells ...

    Abstract Protein disulfide isomerase (PDI) is an essential enzyme involved in oxidative protein folding. PDI is S-nitrosylated in the brains of Alzheimer's disease patients, and S-nitrosylated PDI is considered one of main causes of Alzheimer's disease. However, the mechanisms underlying PDI S-nitrosylation have not yet been elucidated. Because glutathione (GSH) depletion is a pathological feature of Alzheimer's disease, we investigated the effect of GSH depletion on the S-nitrosylation level of PDI. SH-SY5Y cells, which is a human derived neuroblastoma cells, were used in this study. Glutamate and buthionine sulfoximine (BSO) were used as GSH depletors. S-nitrosylated PDI was detected by biotin-switch assay. GSH depletion by glutamate, a cystine/glutamate antiporter xCT inhibitor, increased S-nitrosylated PDI at C343 in SH-SY5Y cells, and induced IRE1α phosphorylation. BSO, a γ-glutamylcysteine synthetase inhibitor, also increased S-nitrosylated PDI and phosphorylated IRE1α upon GSH depletion. Because S-nitrosylated PDI at C343 is stable in neuro cells, S-nitrosylated PDI by GSH depletion progresses to neurodegeneration by the induction of endoplasmic reticulum stress via phosphorylated IRE1α signaling from the early to late stage. Furthermore, treatment with neohesperidin, but not N-acetylcysteine (NAC), improved PDI S-nitrosylation level in GSH-depleted SH-SY5Y cells because nitrosylated compound of NAC induces PDI S-nitrosylation. The results of our study provide a new insight into the mechanisms of neurodegeneration, and may be useful for the development of drugs for Alzheimer's diseases.
    Keywords Alzheimer disease ; S-nitrosylation ; acetylcysteine ; antiporters ; cystine ; endoplasmic reticulum stress ; glutamic acid ; glutathione ; humans ; neohesperidin ; neurodegenerative diseases ; phosphorylation ; protein disulfide-isomerase ; Oxidative stress ; Protein disulfide isomerase ; Alzheimer's disease
    Language English
    Dates of publication 2023-03
    Publishing place Elsevier Inc.
    Document type Article ; Online
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2023.121442
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article: Thrombosis-related characteristics of pregnant women with antithrombin deficiency, protein C deficiency and protein S deficiency in Japan.

    Kobayashi, Takao / Sugiura, Kazuko / Ojima, Toshiyuki / Serizawa, Mariko / Hirai, Kyuya / Morishita, Eriko

    Thrombosis journal

    2024  Volume 22, Issue 1, Page(s) 18

    Abstract: ... characteristics. Antithrombin (AT) deficiency, protein C (PC) deficiency and protein S (PS) deficiency are ...

    Abstract Background:  We previously conducted a primary survey of pregnant women with hereditary thrombophilia based on national surveillance in Japan, but did not examine their thrombosis-related characteristics. Antithrombin (AT) deficiency, protein C (PC) deficiency and protein S (PS) deficiency are the major types of hereditary thrombophilia in Japan.
    Methods: We examined their detailed information related to thrombosis, and evaluated peripartum outcomes in comparison with control data obtained from the Japan Society of Obstetrics and Gynecology.
    Results: Definite or probable AT deficiency, PC deficiency and PS deficiency were observed in 80, 50, and 317 pregnancies, respectively, from 2014 to 2018 in Japan, with prevalence rates among total deliveries of 0.011%, 0.007%, 0.044%. The number of pregnancies with AT, PC and PS deficiency might have been as many as 27, 17 and 108 every year if complete answers had been provided. In the peripartum period of current pregnancies, 27.5% of women with AT deficiency, 28.0% with PC deficiency and 13.2% with PS deficiency developed thrombosis (p < 0.001 vs. control). Pregnant women with AT and PC deficiency were more susceptible to thrombosis than those with PS deficiency (P < 0.01). Of the thromboses, 92.3% occurred during pregnancy, 62.8% at less than 15 gestational weeks. The earliest onset of thrombosis was 5 gestational weeks. Prophylactic anticoagulation significantly prevented the onset of both antepartum and postpartum thrombosis (p < 0.0001). The rate of recurrent pregnancy loss in women with low PC or PS activities was significantly higher than in controls (p < 0.0001); however, it is unknown whether recurrent pregnancy loss is related to hereditary PS deficiency. There seem to have been few serious maternal or fetal/neonatal complications due to placental insufficiency related to a hypercoagulable state other than growth restriction.
    Conclusions: This survey revealed the thrombosis-related characteristics of pregnant women with hereditary thrombophilia in Japan. We suggest prophylactic anticoagulation to prevent maternal or fetal/neonatal complications.
    Language English
    Publishing date 2024-02-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 2118392-2
    ISSN 1477-9560
    ISSN 1477-9560
    DOI 10.1186/s12959-024-00581-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Retroperitoneal Castleman’s Disease

    Shimokihara, Kota / Kawahara, Takashi / Kasahara, Ryo / Kasuga, Jun / Sugiura, Shinpei / Tajiri, Ryosuke / Uemura, Hiroji / Chiba, Kimio

    Case Reports in Oncology

    2019  Volume 12, Issue 3, Page(s) 885–889

    Abstract: Castleman’s disease was first reported in 1954 by Castleman et al. and identified as an uncommon ... lymphoproliferative disorder. In most cases, Castleman’s diseases are detected in the chest, head, and neck. A 71-year-old man ... diseases. Laparoscopic tumorectomy was performed, and the pathological diagnosis was Castleman’s ...

    Institution Department of Urology, Fujisawa Municipal Hospital, Kanagawa, Japan
    Departments of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan
    Department of Pathology, Fujisawa Municipal Hospital, Kanagawa, Japan
    Abstract Castleman’s disease was first reported in 1954 by Castleman et al. and identified as an uncommon lymphoproliferative disorder. In most cases, Castleman’s diseases are detected in the chest, head, and neck. A 71-year-old man was referred to our hospital due to a retroperitoneal tumor in the para-aortic area by computed tomography (CT). Positron emission tomography-CT revealed an uptake in this tumor, suggesting malignant diseases. Laparoscopic tumorectomy was performed, and the pathological diagnosis was Castleman’s disease, hyaline vascular type. No evidence of recurrence was observed 20 months after surgery. We herein report a rare case of retroperitoneal Castleman’s disease.
    Keywords Retroperitoneal tumor ; Castleman’s disease ; Hyaline vascular type
    Language English
    Publishing date 2019-11-27
    Publisher S. Karger AG
    Publishing place Basel, Switzerland
    Document type Article
    Note Case Report ; This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC).
    ZDB-ID 2458961-5
    ISSN 1662-6575 ; 1662-6575
    ISSN (online) 1662-6575
    ISSN 1662-6575
    DOI 10.1159/000504700
    Database Karger publisher's database

    More links

    Kategorien

  8. Article ; Online: Diagnosis of carpal tunnel syndrome using a 10-s grip-and-release test with video and machine learning analysis.

    Tsukamoto, Kazuya / Matsui, Ryota / Sugiura, Yuta / Fujita, Koji

    The Journal of hand surgery, European volume

    2023  Volume 49, Issue 5, Page(s) 634–636

    Abstract: We developed a finger motion-based diagnostic system for carpal tunnel syndrome by analysing 10 second grip-and-release test videos. Using machine learning, it estimated presence of carpal tunnel syndrome (89% sensitivity and 83% specificity) and ... ...

    Abstract We developed a finger motion-based diagnostic system for carpal tunnel syndrome by analysing 10 second grip-and-release test videos. Using machine learning, it estimated presence of carpal tunnel syndrome (89% sensitivity and 83% specificity) and correlated with severity on nerve conduction studies (coefficient 0.68).
    Level of evidence: III.
    MeSH term(s) Carpal Tunnel Syndrome/diagnosis ; Carpal Tunnel Syndrome/physiopathology ; Humans ; Machine Learning ; Middle Aged ; Male ; Female ; Video Recording ; Hand Strength/physiology ; Adult ; Aged ; Sensitivity and Specificity ; Neural Conduction/physiology
    Language English
    Publishing date 2023-11-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 2272801-6
    ISSN 2043-6289 ; 1753-1934
    ISSN (online) 2043-6289
    ISSN 1753-1934
    DOI 10.1177/17531934231214661
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Proton Release Process during the S

    Takemoto, Hiroshi / Sugiura, Miwa / Noguchi, Takumi

    Biochemistry

    2019  Volume 58, Issue 42, Page(s) 4276–4283

    Abstract: Photosynthetic water oxidation takes place at the ... ...

    Abstract Photosynthetic water oxidation takes place at the Mn
    MeSH term(s) Catalytic Domain ; Cyanobacteria/chemistry ; Electron Transport ; Hydrogen Bonding ; Hydrogen-Ion Concentration ; Kinetics ; Oxidation-Reduction/radiation effects ; Photosystem II Protein Complex/chemistry ; Photosystem II Protein Complex/isolation & purification ; Protons ; Spectrophotometry, Infrared/methods ; Water/chemistry
    Chemical Substances Photosystem II Protein Complex ; Protons ; Water (059QF0KO0R)
    Language English
    Publishing date 2019-10-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1108-3
    ISSN 1520-4995 ; 0006-2960
    ISSN (online) 1520-4995
    ISSN 0006-2960
    DOI 10.1021/acs.biochem.9b00680
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Glucose-induced oxidative stress leads to in S-nitrosylation of protein disulfide isomerase in neuroblastoma cells.

    Ogura, Jiro / Sugiura, Hiroki / Tanaka, Atsushi / Ono, Shinji / Sato, Toshiyuki / Sato, Toshihiro / Maekawa, Masamitsu / Yamaguchi, Hiroaki / Mano, Nariyasu

    Biochimica et biophysica acta. General subjects

    2021  Volume 1865, Issue 11, Page(s) 129998

    Abstract: ... cognitive disorders. Protein disulfide isomerase (PDI) is an enzyme for oxidative protein folding. PDI S-nitrosylation ... the relationship between PDI S-nitrosylation and diabetes.: Methods: We used SH-SY5Y cells cultured in high ... glucose media.: Results: S-nitrosylated PDI level increased at 7 days and remained high till 28 days ...

    Abstract Background: Dementia places a significant burden on both patients and caregivers. Since diabetes is a risk factor for dementia, it is imperative to identify the relationship between diabetes and cognitive disorders. Protein disulfide isomerase (PDI) is an enzyme for oxidative protein folding. PDI S-nitrosylation is observed in the brain tissues of Alzheimer's disease patients. The aim of this study is to clarify the relationship between PDI S-nitrosylation and diabetes.
    Methods: We used SH-SY5Y cells cultured in high-glucose media.
    Results: S-nitrosylated PDI level increased at 7 days and remained high till 28 days in SH-SY5Y cells cultured in high-glucose media. Using PDI wild-type- or PDI C343S-expressing SH-SY5Y cells, PDI C343 was identified as the site of glucose-induced S-nitrosylation. IRE1α and PERK were phosphorylated at day 14 in the SH-SY5Y cells cultured in high-glucose media, and the phosphorylated status was maintained to day 28. To determine the effect of S-nitrosylated PDI on endoplasmic reticulum stress signaling, SH-SY5Y cells were treated with S-nitrosocystein (SNOC) for 30 min, following which the medium was replaced with SNOC-free media and the cells were cultured for 24 h. Only phosphorylated IRE1α treated with SNOC was associated with PDI S-nitrosylation. Neohesperidin, a flavonoid in citrus fruits, is a natural antioxidant. The treatment with neohesperidin in the final 7 days of glucose loading reversed PDI S-nitrosylation and improved cell proliferation.
    Conclusion: Glucose loading leads to S-nitrosylation of PDI C343 and induces neurodegeneration via IRE1α phosphorylation.
    General significance: The results may be useful for designing curative treatment strategies for dementia.
    MeSH term(s) Glucose/metabolism ; Humans ; Neuroblastoma/metabolism ; Oxidative Stress ; Protein Disulfide-Isomerases/metabolism ; Tumor Cells, Cultured
    Chemical Substances Protein Disulfide-Isomerases (EC 5.3.4.1) ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2021-08-30
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 60-7
    ISSN 1872-8006 ; 1879-2596 ; 1879-260X ; 1879-2642 ; 1879-2618 ; 1879-2650 ; 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    ISSN (online) 1872-8006 ; 1879-2596 ; 1879-260X ; 1879-2642 ; 1879-2618 ; 1879-2650
    ISSN 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    DOI 10.1016/j.bbagen.2021.129998
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top